Buoyed by economic development and demographic changes, India has generated a lot of interest for Pharmaceutical, Biotechnology, and Healthcare companies. Globalisation of the pharmaceutical, biotechnology, and healthcare services has provided huge opportunities that have made the industry leaders sit up and pitch for a share in the growing pie. Amidst the opportunities lie numerous challenges and pitfalls. The enthusiasm needs to be tempered with wisdom and diligence. Issues like regulation, economics, logistics, and culture must be understood while keeping profitability in view.

The Healthcare Club at the Indian School of Business is hosting the Healthcare and Pharma Conclave 'Destination India - Challenges and Opportunities' on Saturday, September 26, 2009. This year, the Conclave will bring together global and Indian Pharmaceutical, Biotechnology and Healthcare companies on a single platform to discuss the challenges of doing business in India and the opportunities that India offers for partnerships, outsourcing, R&D, innovation, healthcare services, drug development, and manufacturing.

The Healthcare and Pharma Conclave - 2009 intends to probe into the changing dynamics of the industry, and trace the road ahead, through a series of insightful talks and discussions involving industry leaders.

The Conclave is targeted at managers in pharmaceutical, biotechnology, healthcare, consulting, investment banking, PE, and VC firms, and also students interested in the pharmaceutical, biotechnology, and healthcare industries in India and abroad.